We also isolated control male ES cell clones (hereafter called CRISPR-controls) derived from the BC cross, which were subject to the CRISPR/Cas9 treatment but did not exhibit a deletion of Kdm6a (Additional file 8: Table S8A). The gene discussed is KDM6A; the disease is breast cancer.